LifeClean International AB (SE:LCLEAN)
:LCLEAN
Want to see SE:LCLEAN full AI Analyst Report?
Top Page
LifeClean International AB
(LCLEAN)
Select Model
Select Model
Rating:42Neutral
Price Target:
kr0.06
▼(-36.67% Downside)
Action:Reiterated
Date:05/12/26
The score is held down primarily by weak financial performance—deep losses, negative gross profit, persistent cash burn, and high leverage. Technicals are mixed with neutral RSI and oversold Stoch but weak longer-term moving-average positioning. Valuation provides limited support due to negative earnings and no dividend.
Positive Factors
Proprietary product specialization
LifeClean's focus on infection control and proprietary disinfection chemistry signals a durable product differentiation. Specialized chemistry and implementation support create higher technical barriers, recurring demand in healthcare settings, and sticky B2B relationships that support sustainable revenue streams.
Negative Factors
Negative gross profit
Negative gross profit indicates the company is not covering direct product costs, revealing structurally weak unit economics. Without durable improvements to pricing, input costs, or product mix, gross-losses will continue to undermine any operational leverage and prevent sustainable profitability.
Read all positive and negative factors
Positive Factors
Negative Factors
Proprietary product specialization
LifeClean's focus on infection control and proprietary disinfection chemistry signals a durable product differentiation. Specialized chemistry and implementation support create higher technical barriers, recurring demand in healthcare settings, and sticky B2B relationships that support sustainable revenue streams.
Read all positive factors
LifeClean International AB (LCLEAN) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr58.05M
Dividend YieldN/A
Average Volume (3M)474.43K
Price to Earnings (P/E)―
Beta (1Y)0.11
Revenue Growth-8.89%
EPS Growth80.71%
CountrySE
Employees31
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)-0.12
Shares Outstanding1,025,575,800
10 Day Avg. Volume395,019
30 Day Avg. Volume474,432
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)7.74
Price to Sales (P/S)0.48
P/FCF Ratio-0.92
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.06
Revenue Forecast (FY)kr135.00M
LifeClean International AB Business Overview & Revenue Model
Company Description
LifeClean International AB (publ) researches, produces, markets, and sells disinfection products in Sweden. It has developed a patented spore, fungal, biofilm, bacterial, and virus-killing surface disinfection for equipment and surfaces, such as f...
How the Company Makes Money
LifeClean International AB makes money primarily by selling its disinfection products (and any bundled solutions built around those products) to professional customers. Revenue is generated through product sales to end customers and/or via distrib...
LifeClean International AB Financial Statement Overview
Summary
Income Statement
12
Very Negative
Balance Sheet
18
Very Negative
Cash Flow
10
Very Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 54.74M | 54.63M | 61.15M | 52.50M | 47.18M | 53.36M |
| Gross Profit | -48.29M | -35.33M | 26.82M | 22.77M | 19.52M | -30.81M |
| EBITDA | -24.33M | -26.03M | -40.87M | -32.39M | -27.79M | -26.05M |
| Net Income | -33.16M | -35.66M | -53.72M | -44.24M | -36.09M | -32.75M |
Balance Sheet | ||||||
| Total Assets | 44.19M | 48.10M | 61.80M | 68.61M | 76.37M | 82.59M |
| Cash, Cash Equivalents and Short-Term Investments | 2.14M | 6.88M | 10.57M | 8.29M | 11.61M | 8.85M |
| Total Debt | 21.37M | 27.36M | 44.90M | 47.84M | 32.38M | 18.54M |
| Total Liabilities | 40.98M | 44.73M | 65.43M | 67.29M | 62.56M | 32.70M |
| Stockholders Equity | 3.21M | 3.36M | -3.63M | 1.31M | 13.81M | 49.89M |
Cash Flow | ||||||
| Free Cash Flow | -22.77M | -28.28M | -42.66M | -39.99M | -20.07M | -23.01M |
| Operating Cash Flow | -22.67M | -28.23M | -40.83M | -35.46M | -16.96M | -21.79M |
| Investing Cash Flow | -372.00K | 45.00K | -1.85M | -4.54M | -3.13M | -36.51M |
| Financing Cash Flow | 19.01M | 24.50M | 44.96M | 36.67M | 22.84M | 24.68M |
LifeClean International AB Technical Analysis
Negative
0.09
Price Trends
0.06
Negative
0.06
Negative
0.12
Negative
Market Momentum
>-0.01
Positive
42.06
Neutral
14.91
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:LCLEAN, the sentiment is Negative. The current price of 0.09 is above the 20-day moving average (MA) of 0.07, above the 50-day MA of 0.06, and below the 200-day MA of 0.12, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 42.06 is Neutral, neither overbought nor oversold. The STOCH value of 14.91 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:LCLEAN.
LifeClean International AB Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
51 Neutral | kr104.40M | 18.43 | 5.40% | ― | 9.35% | -59.04% | |
50 Neutral | kr237.43M | -47.22 | -7.45% | 2.89% | -16.65% | 48.43% | |
44 Neutral | kr56.02M | -3.81 | 437.24% | ― | 268.54% | 94.27% | |
42 Neutral | kr58.05M | -0.67 | -572.32% | ― | -8.89% | 80.71% |
* Consumer Defensive Sector Average
SE:LCLEAN
LifeClean International AB
0.05
-0.16
-74.29%
SE:QLIFE
Qlife Holding AB
2.01
-0.10
-4.92%
SE:POLYG
Polygiene AB
6.22
-6.37
-50.61%
SE:CLEM
Clemondo Group AB
7.60
-3.20
-29.63%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.